AzTrials
AzTrials

Patellofemoral Pain SyndromeNCT05348850

Quadriceps Muscle Contractile Properties and Functional Performance

An observational study of Patellofemoral Pain Syndrome, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the association between tensiomyography parameters (from rectus femoris, vastus lateralis and vastus medialis) and functional abilities in runners with patellofemoral pain syndrome. Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Patellofemoral Pain Syndrome
What is being tested?
Tensiomayography (TMG)
Type of treatment
Medical device
How many people
30 participants
Where
1 siteEgypt
Study dates
20 Apr 2022to 1 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: 30 Distance runners selected from Egyptian clubs will participate in the study.

Who may be able to join

  • The athletes age range between 18-30 years old will participate in this study.
  • Both males and females will participate in this study.
  • All athletes will be selected from long-distance runners.
  • All athletes have an average running period (6 days per week and 5 hours per day).

Who cannot join

  • Athletes with foot deformities such as hallux valgus, foot supination, pes planus, and pes cavus,
  • Athletes with biomechanical abnormalities and complications affecting walking ability and performance.
  • History of lower limbs or back surgery or injury.
  • Structural or functional leg length discrepancy.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Haven Health care

    El-Sheikh Zayed City

Other trials in Egypt

About this study

Official title: Correlation Between Contractile Properties of Quadriceps Muscle and Functional Performance in Runners With Patellofemoral Pain Syndrome

The aim of this study is to investigate the association between tensiomyography parameters (from rectus femoris, vastus lateralis and vastus medialis) and functional abilities in runners with patellofemoral pain syndrome.

Read the detailed description

Running is one of the most widespread activities during which overuse injuries of the lower extremity occur. Long-distance running is very popular among participants of recreational sports . In 2008, about 11.5% of the population in the United States ran and, of this group, 3.4% ran on average two times a week or more. In Europe, it is estimated that 36% of the population aged 15-65 years are recreational runners.

Most running-related injuries occur in the lower extremities. The most common anatomical site of running injuries is the knee.

Risk factors for running injuries have been well investigated , However, because of the heterogeneity of the studies (e.g., definition of injury, recreational or elite runners, and short- or long-distance runners), no clear overview is available regarding the most important risk factors for running injuries. Increased training volume per week in male runners, and a history of previous injuries for runners, are known significant risk factors for running injuries.

The various purported risk factors for running injuries are commonly divided into intrinsic and extrinsic risk factors. Intrinsic risk factors include mostly anatomic and other variables that are innate to the individual, such as gender, age, height, weight, personality type (e.g., aggressive, passive), and anatomic factors such as femoral anteversion, genu varus or valgus, pes planus or cavus, bone density, muscular flexibility, and leg-length discrepancies. Extrinsic risk factors include training variables such as mileage, hill running, pace, interval training, equipment (shoes, shoe inserts), and training surfaces.

Patellofemoral pain syndrome is the most common overuse injury of the lower extremity, and is particularly prevalent in those who are physically active. For example, approximately 2.5 million runners will be diagnosed with PFPS in a given year. PFPS also is a significant problem in the military as it has been reported that 37% of recruits develop PFPS while in basic combat training. Females are reported to be at greater risks for PFPS than their male counterparts. Alarmingly, 70% to 90% of individuals with PFPS have recurrent or chronic pain, In addition, the result of a recent study suggest that having PFPS as a younger individual may predispose one to develop patellofemoral osteoarthritis later in life.

One of the most common risk factors of patellofemoral pain syndrome is the imbalance of the quadriceps musculature and maltracking of the patella are 2 potential factors that may lead to PFP.

The nature of PFP is multifactorial, and many risk factors have been associated with this condition. This come in agreement with several authors who reported that patellofemoral pain syndrome is one of the most common injuries in runners.

Being tested
Tensiomayography (TMG)
Keywords
Runners
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tensiomayography (TMG)Device

    Quadriceps muscle contractile properties will be assessed using tensiomayography

Study groups in NCT05348850
Study groupRoleWhat they receive
Study GroupAthletes with patellofemoral pain syndrome will be selected Muscle contractile properties and functional performance will be assessed for athletes with patellofemoral pain syndrome . Data will be collected from all athletes regarding age, gender, training intensity running experience and previous injuries. By the end of the assessment it will be detected if muscle contractile properties of vastus medialis and vastus lateralis is a determinant factor that influence functional performance in runners with patellofemoral pain syndrome.
Receives: Device: Tensiomayography (TMG)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Contractile properties of Quadriceps muscle for 30 runners with patellofemoral pain syndrome

    Will be assessed using Tensiomayography

    Measured: measured at the baseline as it is a cross sectional study

  2. Anteromedial lunge Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Anteromedial lunge test will be performed by each athlete for 3 trails with a 3 min recovery period between .

    Measured: measured at the baseline as it is a cross sectional study

  3. Step-down Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Step-down test will be performed by each athlete for 3 trails with a 3 min recovery

    Measured: measured at the baseline as it is a cross sectional study

  4. Balance and reach Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Balance and reach test will be performed by each athlete for 3 trails with a 3 min recovery

    Measured: measured at the baseline as it is a cross sectional study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2022
  2. Study start20 Apr 2022
  3. Primary completion20 Sep 2022
  4. Study completion1 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05348850
Sponsor's protocol ID
P.T.REC/012/003382
Status last verified
Jan 2023
First submitted
13 Apr 2022
Last updated
17 Jan 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Patellofemoral Pain Syndrome, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Contractile properties of Quadriceps muscle for 30 runners with patellofemoral pain syndrome (time frame: measured at the baseline as it is a cross sectional study). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in